1. Home
  2. ICD-10-PCS
  3. 3E0F7GC
  4. Share
  5. Feedback

ICD 10 Code 3E0F7GC

Introduction of Other Therapeutic Substance into Respiratory Tract, Via Natural or Artificial Opening
“Introduce of Oth Therap Subst into Resp Tract, Via Opening” for short

3E0F7GC is a valid billable ICD-10 procedure code for Introduction of Other Therapeutic Substance into Respiratory Tract, Via Natural or Artificial Opening. It is found in the 2025 version of the ICD-10 Procedure Coding System (PCS) and can be used in all HIPAA-covered transactions from Oct 01, 2024 - Sep 30, 2025.

Introduction involves:
Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products.

Via Natural or Artificial Opening approach involves:
Entry of instrumentation through a natural or artificial external opening to reach the site of the procedure

Other Therapeutic Substance device includes:

  • Idarucizumab, Pradaxa(R)(dabigatran) reversal agent
  • Praxbind(R) (idarucizumab), Pradaxa(R)(dabigatran) reversal agent

ICD-10-PCS code structure for 3E0F7GC — See Table View

1: Section 3 Administration
2: Body System E Physiological Systems and Anatomical Regions
3: Root Operation 0 Introduction
4: Body Part F Respiratory Tract
5: Approach 7 Via Natural or Artificial Opening
6: Device G Other Therapeutic Substance
7: Qualifier C Other Substance

See also

  • The ICD-10-PCS Index of common procedure terms.
  • Administration terms in the ICD-10-PCS Definitions table. These definitions may also provide additional explanation and/or examples within this section.
  • The ICD-10-PCS Device Aggregation Table containing entries that correlate a specific ICD-10-PCS device value with a general device value to be used in tables containing only general device values.